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BY-NC-ND license (http://creativecomAbstract Background/Purpose: Only limited information is available about the detailed
characteristics of qnrD, a plasmid-mediated quinolone resistance (PMQR) gene. This study
aimed to understand the distribution of qnrD and the characterization of qnrD-carrying plas-
mids in Proteeae.
Methods: The distribution of qnrD genes was investigated by polymerase chain reaction (PCR)
amplification in 203 consecutive nonduplicate clinical isolates of Proteeae collected from in-
patients at the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. The
minimum inhibitory concentrations (MICs) of antibiotics were measured by agar dilution
method and other PMQR determinants were also determined by PCR. qnrD was positioned
via Southern hybridization and the transferability of qnrD-carrying plasmids was achieved by
conjugation experiment. The genetic environment of qnrD was investigated by sequencing,
and chromosomal polymorphism for qnrD-positive strains was analyzed by pulsed-field gel
electrophoresis (PFGE).
Results: Forty strains carried qnrD, showing decreased fluoroquinolone susceptibility or low-
level fluoroquinolone resistance. qnrD was encoded on the plasmid of about 2.7 kb or 5.2 kb
in length, which cannot be transferred by liquid conjugation or filter mating, but can be suc-
cessfully transferred by transduction. The transformants showed 62.5e300-fold increases in
the MICs of quinolones compared with the recipient. The plasmids carrying qnrD showed a high
similarity with that of Providencia spp. and Proteus vulgaris. PFGE analysis demonstrated that
these isolates were divergent and not clone related.t of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang
0, China.
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reservoir; furthermore, qnrD could be transferred and spread within the same or across
different bacterial species if the plasmids acquired mobile elements under antimicrobial selec-
tive pressures.
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Fluoroquinolones have a wide spectrum of in vitro anti-
bacterial activity, particularly against Gram-negative bac-
teria. Unfortunately, the widespread use of this antibiotic
in clinical medicine has resulted in the resistance to these
agents becoming more common among Enter-
obacteriaceae. Quinolone resistance is mainly due to mu-
tations in the subunits of DNA gyrase and topoisomerase
IV.1e3 Although plasmid-mediated quinolone resistance
(PMQR) determinants confer only low-level resistance to
quinolones, they can increase the minimum inhibitory
concentrations (MICs) of quinolones; moreover, these
changes are sufficient to facilitate the selection of mutants
with higher levels of resistance.4 Besides, PMQR genes are
located on transferable plasmids and play an important role
in quinolone resistance. To date, a number of PMQR de-
terminants have been detected and studied, including the
qnr genes (A, B, S, C, D, and VC); the aac(60)-Ib-cr gene; the
qepA gene; and oqxAB, a new PMQR determinant.5,6
The qnrD gene was first described on a 4270-bp plasmid
in a human clinical Salmonella enterica isolate from China
in 2009, but there has been only little information about
the detailed characteristics of qnrD due to the low preva-
lence of this PMQR gene in clinical isolates.5 The qnrD gene
was found on small plasmids, whose size was about 2.7 kb
or 4.2 kb; meanwhile, the qnrD-carrying plasmids typically
had a simple backbone and were stably maintained.
Thomas Guillard had hypothesized that qnrD could be more
closely related to the Proteeae bacteria than the other qnr
genes and perhaps originated from them.7 In this study, we
investigated 203 Proteeae strains isolated from humans to
understand the distribution of qnrD gene and the charac-
terization of the qnrD-carrying plasmids.Methods
qnrD detection in Proteeae clinical isolates
A total of 203 consecutive nonduplicate Proteeae clinical
isolates (100 Morganella morganii, 85 Proteus mirabilis, 15
Proteus vulgaris, and 3 Providencia rettgeri isolates) were
collected and screened from inpatients at the First Affili-
ated Hospital of Wenzhou Medical University, Wenzhou,
China. All isolates were identified by a VITEK 2 system
(bioMe´rieux, France). The total DNAs of all isolates were
obtained using an AxyPrep Bacterial Genomic DNA Miniprep
kit (Axygen Scientific, Union City, CA, USA) and were used
as polymerase chain reaction (PCR) templates. TheChen L, et al., Description and p
f Microbiology, Immunology and Ipresence of qnrD was detected for all isolates by PCR, and
PCR products were confirmed by sequencing.
Antimicrobial susceptibility testing
The MICs of ciprofloxacin, norfloxacin, levofloxacin, and
nalidixic acid were determined by the agar dilution method
or broth microdilution method for qnrD-positive strains and
qnrD-negative strains according to the relevant Clinical and
Laboratory Standards Institute 2014 guidelines.8 Quality
control for the MIC analyses was performed with Escher-
ichia coli ATCC 25922. The MIC50 and MIC90 were also re-
ported to provide preliminary information about how the
qnrD gene contributes to the MIC of quinolones.
Investigation of other related resistance
determinants
All qnrD-positive strains were also screened for other PMQR
determinants, including qnrA, qnrB, qnrS, aac(60)-Ib-cr,
qnrC, qepA, oqxA, and oqxB by PCR using primers as
described previously.9 The positive PCR products were
screened by electrophoresis on 1.0% agarose gel and were
sequenced by Shanghai Majorbio Bio-Pharm Technology Co.
(Shanghai, China). Nucleotide sequences were analyzed
and compared using Basic Local Alignment Search Tool
(BLAST; http://www.ncbi.nlm.nih.gov/BLAST).
Plasmid analysis and Southern hybridization
Plasmids of qnrD-positive strains were extracted by the
QIAGEN Plasmids Midi Kit (Qiagen, GmbH, Germany).
Plasmid DNAs were separated by electrophoresis on a 0.8%
agarose gel at a constant voltage of 100 V for 1 hour and
then transferred onto a nylon membrane (Roche, Man-
nheim, Germany). Southern hybridization was performed
according to standard protocols.7 The qnrD-specific probe
was labeled using a DIG High Prime DNA labeling kit (Roche,
Sant Cugat del Valle`s, Spain) following the manufacturer’s
instructions. Plasmids extracted from E. coli V517 (sizes,
54 kb, 5.6 kb, 5.1 kb, 3.9 kb, 3.0 kb, 2.7 kb, and 2.1 kb)
were used as the standards for plasmid size.
Conjugal transfer experiments
Conjugation experiments were performed using rifampin-
resistant E. coli C600 and sodium azide-resistant E. coli J53
as the recipient strains. In brief, overnight cultures of the
donor strain (500 mL) and recipient strain (500 mL) werelasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
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for 24 hours at 35C. Then, the mixture was inoculated on
Mueller-Hinton agar plates containing rifampin (600 mg/mL)
or sodium azide (100 mg/mL) plus ampicillin (100 mg/mL) or
nalidixic acid (50 mg/mL) or ciprofloxacin (0.03 mg/mL and
0.06 mg/mL), or gentamicin (4 mg/mL) for 24 hours at 35C.
Filter mating was initiated with Luria-Bertani broth
suspensions of donor and recipient cells prepared from
their 18-hour growth on blood agar, cultured for 4 hours
with shaking. Equal portions (1 mL) of donor and recipient
cells were mixed and filtered through a 25-mm nitrocellu-
lose filter (0.45-mm pore diameter), which was then incu-
bated on blood agar media for 18 hours at 37C. The
resultant growth was suspended in 2 mL of the broth me-
dium, diluted, and plated on the aforementioned selective
media for 24 hours at 35C.
As previously described, plasmid transfer by trans-
duction was performed by transformation experiments
using JM109 as receptor.8 Transformants were selected on
Mueller-Hinton agar plates containing ciprofloxacin
(0.06 mg/mL).
PCR analysis was performed to screen the resistant
genes, and MICs of quinolones were determined by the agar
dilution method for transconjugants and transformants.
Sequence of plasmids
To investigate the genetic environment of qnrD, such as
mobile elements, the whole sequence of the plasmid
harboring the qnrD gene was obtained by PCR walking.
pM60, pMB5, pMB18, and pMSL46 (extracted from M60, B5,
B18, and SL46, respectively) were randomly selected and
sequenced. We predicted the open reading frame (ORF)
using the ORF Finder website (http://www.ncbi.nlm.nih.
gov/gorf/gorf.html) and matched the whole sequence
with sequences in GenBank database. The structure and
GþC contents of the plasmid were also investigated.
Detection of mutations in the topoisomerase II and
IV genes
The quinolone resistance-determinant regions (QRDRs) of
gyrA, gyrB, parC, and parE in all qnrD-positive strains were
amplified as described previously.10 The positive PCR
products were sequenced by Shanghai Majorbio Bio-Pharm
Technology Co. and sequence data were analyzed using
BLAST.
Pulsed-field gel electrophoresis analysis
Chromosomal polymorphism was analyzed by pulsed-field
gel electrophoresis (PFGE) using the XbaI or sfiI (special for
Proteus) restriction enzyme (Takara Bio, Inc.) for qnrD-
positive strains. The DNA fragments were separated using a
CHEF-Mapper XA PFGE system (Bio-Rad, Hercules, CA, USA)
for 22 hours at 6 V/cm and 14C, with a pulse angle of 120
and pulse duration from 5 seconds to 25 seconds. The re-
striction patterns were analyzed using the Quality One
software (Bio-Rad) and interpreted according to the criteria
proposed by Tenover et al.11Please cite this article in press as: Chen L, et al., Description and p
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Detection of resistance determinants and
antimicrobial susceptibility testing
The qnrD gene screening of the 203 clinical isolates iden-
tified 40 (19.7%) strains carrying qnrD: 17 M. morganii
(M36eM110), 20 P. mirabilis (B2eB84), two P. vulgaris (B85
and B95), and one P. rettgeri (SL46). A total of 14 strains
were found to co-produce other resistance genes: 20% (5 M.
morganii and 3 P. mirabilis) of the isolates were positive for
aac(60)-Ib-cr, 5.0% (1 P. mirabilis and 1 P. vulgaris) isolates
were positive for qnrB, 7.5% (3 M. morganii) were positive
for qepA, and 12.5% (2 M. morganii, 2 P. mirabilis, and 1 P.
vulgaris) were positive for oqxAB. The genotypic charac-
teristics and susceptibilities of qnrD-positive isolates are
presented in Table 1. The MIC50 and MIC90 for the qnrD-
positive strains were at least two or more dilutions higher
than that for the qnrD-negative strains. The detailed data
are presented in Table 2.
Plasmid analysis and Southern hybridization
The plasmid profiles indicated that all the qnrD-positive
isolates had more than two plasmids and Southern blot
analysis of the qnrD-positive isolates hybridized with the
qnrD-specific probe confirmed that qnrD was encoded on
the 2.7- or 5.2-kb plasmid (Figure 1).
Conjugal transfer experiments
The qnrD-positive isolates failed to transfer qnrD to E. coli
C600 or E. coli J53 through either liquid or mating-out as-
says despite several attempts. Only the aac(60)-Ib-cr gene
of two isolates (M72 and B43) were successfully transferred
to E. coli C600. The transconjugant exhibited a phenotype
of reduced susceptibility to ciprofloxacin and was PCR
confirmed to carry the aac(60)-Ib-cr gene similar to that of
the original isolates.
Plasmid harboring qnrD was successfully transferred by
transduction. qnrD was detected in all transformants,
which showed 62.5- to 300-fold increases in the MICs of
quinolones compared with JM109 (Table 3).
Sequence of plasmid
The length of the whole sequences of pM60, pMB5, pMB18,
and pMSL46 was 2683 bp, 2683 bp, 5201 bp, and 2683 bp,
respectively. pM60, pMB5, and pMSL46 exhibited 99.9%
identity with each other and they had 2187-bp bases that
exhibited 99% identify with pMB18. All the plasmids were
aligned with p2007057, which was a qnrD-carrying plasmid
first described in a human clinical S. enterica isolate. Only
54.3% of the whole sequences of pM60, pMB5, and pMSL46,
and 30.0% of pMB18 exhibitedw98% identity with p2007057,
respectively. By contrast pM60, pMB5, and pMSL46 exhibited
100% identity with pCGP248 (a qnrD-carrying plasmid in P.
mirabilis), and 57.0% and 61.0% of the pMB18 sequences
exhibited 99% identity with pCGP248 and p3M-2B (a qnrD-
carrying plasmid in Proteus spp.), respectively.lasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
Table 1 The resistance determinants and susceptibilities of qnrD-positive isolates.
Strain Minimum inhibitory concentrations (mg/mL) Plasmid-mediated quinolone
resistance genesNAL CIP LEV NOR
M36 >256 32 16 >64 qnrD
M46 >256 16 2 8 qnrD, aac(60)-Ib-cr, qepA
M51 >256 8 8 8 qnrD
M56 4 0.125 0.125 0.125 qnrD
M59 >256 4 4 8 qnrD
M60 >256 32 8 >64 qnrD
M65 >256 8 2 4 qnrD, qepA
M69 >256 1 2 4 qnrD, qepA
M72 >256 64 4 32 qnrD, aac(60)-Ib-cr, oqxAB
M74 >256 2 4 4 qnrD
M78 >256 1 1 0.25 qnrD
M82 >256 32 8 8 qnrD
M86 >256 1 1 0.5 qnrD
M90 >256 4 4 8 qnrD, aac(60)-Ib-cr
M91 8 0.125 0.25 4 qnrD, aac(60)-Ib-cr, oqxAB
M103 2 0.5 0.5 0.25 qnrD
M110 >256 16 4 32 qnrD, aac(60)-Ib-cr
B2 8 0.25 0.5 1 qnrD
B3 >256 0.125 0.5 1 qnrD
B5 >256 8 8 16 qnrD, aac(60)-Ib-cr
B8 >256 4 8 16 qnrD, aac(60)-Ib-cr
B15 >256 0.25 0.5 1 qnrD
B16 >256 4 8 4 qnrD
B18 >256 16 8 16 qnrD
B24 >256 2 4 4 qnrD
B26 4 0.03 0.125 0.5 qnrD
B27 >256 8 8 8 qnrD
B30 >256 1 2 2 qnrD, oqxAB
B33 >256 0.5 0.5 0.25 qnrD
B46 >256 0.25 0.5 0.5 qnrD
B48 >256 4 2 4 qnrD, oqxAB
B57 >256 0.5 0.25 1 qnrD, qnrB
B59 >256 0.25 0.5 0.125 qnrD
B65 >256 0.06 0.125 0.25 qnrD
B76 >256 8 0.25 4 qnrD
B81 8 0.25 0.5 0.5 qnrD
B84 >256 16 8 16 qnrD
B89 >256 16 16 16 qnrD, qnrB
B95 >256 0.25 1 1 qnrD, aac(60)-Ib-cr, oqxAB
SL46 >256 4 16 32 qnrD
CIP Z ciprofloxacin; LVX Z levofloxacin; NAL Z nalidixic acid; NOR Z norfloxacin.
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at GenBank (accession numbers KF813021.1 and
KM577619.1). pM60, pMB5, and pMSL46 contained four pu-
tative ORFs with qnrD, and the plasmid pMB18 contained six
ORFs. It is necessary to point out that none of these three
plasmids carried any other resistance gene or any mob-like
element. The GþC contents of qnrD, pM60, and pMB18
(38.14%, 40.43%, and 41.74%, respectively) are close to
those of Providencia spp. (38e40%) and Proteus spp.
(38e39%) but not close to those of S. enterica (48%).
Furthermore, several segments of these plasmids’ genomes
showed partial homology with the genome of Proteeae. For
detailed information, please refer to Figure 2.Please cite this article in press as: Chen L, et al., Description and p
Wenzhou, Southern China, Journal of Microbiology, Immunology and ITopoisomerase mutations
We could not obtain the positive amplification products of
QRDRs in M. morganii despite many attempts. PCR
sequencing of PCR products of QRDRs in P. mirabilis, P.
vulgaris, and P. rettgeri showed no mutations.PFGE typing
PFGE analysis of the qnrD-positive strains belonging to the
same species was distinct because these strains shared less
than 70% (M. morganii) or 60% (Proteus) similaritylasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
Table 2 MIC50 and MIC90 for qnrD-positive strains and
qnrD-negative strains.
Drug MIC50 (mg/mL) MIC90 (mg/mL)
qnrDþ qnrD qnrDþ qnrD
NAL >256 >256 >256 >256
CIP 2 0.5 16 4
LVX 2 1 8 4
NOR 4 0.25 32 16
CIP Z ciprofloxacin; LVX Z levofloxacin; MIC Z minimum
inhibitory concentration; NAL Z nalidixic acid;
NOR Z norfloxacin.
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clone related, suggesting that the qnrD gene had emerged
independently.
Discussion
PMQR determinants were widely distributed in Enter-
obacteriaceae.12 To our knowledge, there is no report on
the high prevalence of the qnrD gene in clinical isolates of
Proteeae. In this study, the distribution characteristics of
the qnrD gene and other related resistance determinants
among 203 Proteeae isolates in a Chinese teaching hospitalFigure 1. (A) Southern blot of the gel shown in Panel (B) after hy
qnrD-positive strains and V517 (2.1 kb, 2.7 kb, 3.0 kb, 3.9 kb, and
Table 3 Antibiotic susceptibility of JM109 and transformants.
Strain
NAL (range) CIP (rang
JM109 1 0.002
Transformants 8 (1e8) 0.5 (0.12
CIP Z ciprofloxacin; LVX Z levofloxacin; MIC Z minimum inhibitory
Please cite this article in press as: Chen L, et al., Description and p
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reached up to 19.7%, which was much higher than the
previous study.7
The qnrD gene is the latest PMQR determinant. Since it
was first described in 2009 in human clinical S. enterica iso-
lates from China,13 there have been only a few reports
regarding the qnrD determinant in human clinical isolates.
The isolates found to be positive for this determinant are as
follows: two P. mirabilis isolates and one Pseudomonas
aeruginosa isolate in Nigeria in 201014; four P. mirabilis iso-
lates, one M. morganii isolate in Italy, and two P. rettgeri
isolates in France in 201115; and 12 P. mirabilis isolates and
two M. morganii isolates15 in China in 2012.16 In this study, a
higher positive rate (24.6%, 50/203) of the qnrD determinant
was detected in our Proteeae isolates than in the previous
study. The qnr genes have rarely been observed in Proteeae,
but interestingly, qnrD plasmids seem to bemore common in
Proteeae.17 In addition, the difference in quinolones sus-
ceptibility between the qnrD-positive strains and the qnrD-
negative strains proved that qnrD contributed to quinolone
resistance primarily.
A total of 14 strains were found to co-produce other
PMQR genes, and it was worth mentioning that aac(60)-Ib-cr
and oqxAB, two other plasmid-mediated resistance mech-
anisms, were also identified in our investigation. One
important point is that although these mechanisms cause
only low-level resistance, they favor and complement thebridization with the qnrD probe. (B) Plasmid profiles of part of
5.1 kb) on 0.8% agarose gel.
MIC or MIC90 (mg/mL)
e) NOR (range) LVX (range)
0.015 0.002
5e1) 2 (0.125e2) 0.5 (0.125e1)
concentration; NAL Z nalidixic acid; NOR Z norfloxacin.
lasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
Figure 2. Structure of (A) pM60 and (B) pMB18 and main alignment results (dotted lines). pM60, pMB5, and pMSL46 exhibited
99.9% identity with each other, and therefore, we selected pM60 as the representative here. GTPZ guanosine-50-triphosphate; S.
enterica Z Salmonella enterica.
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first detection of the oqxAB genes in the clinical isolates of
M. morganii. Antimicrobial-susceptibility results showed
decreased fluoroquinolone susceptibility or low-level fluo-
roquinolone resistance was exhibited by most isolates with
qnrD and other PMQRs, reflecting the importance of PMQRsPlease cite this article in press as: Chen L, et al., Description and p
Wenzhou, Southern China, Journal of Microbiology, Immunology and Ideterminants in fluoroquinolone-resistance mechanisms.
However, the isolate M91 co-carrying qnrD, aac(60)-Ib-cr,
and oqxAB was found to be sensitive to ciprofloxacin and
levofloxacin. Therefore, qnr determinants alone may not
confer resistance to quinolones, but they can supplement
other quinolone-resistance mechanisms.19lasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
Figure 3. Pulsed-field gel electrophoresis analysis of (A) 17 qnrD-positive Morganella morganii and (B) 22 qnrD-positive Proteus.
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2.7 kb in length, have been identified in human clinical
isolates.13,16,20 In our research, DNA hybridization showed
that qnrD in M. morganii, P. rettgeri, and most Proteus
isolates was located on a w2.7-kb plasmid, with the
exception of three P. mirabilis isolates (B18, B84, and B89),
in which it was on a w5.2-kb plasmid, which is the first
report of a new plasmid containing qnrD. In addition, it is
worth pointing out that all the three aforementioned
strains showed higher fluoroquinolone resistance than the
other qnrD-carrying strains.
Previous studies have reported that the qnr genes were
related to integron structures13,19; however, none of our
plasmids carried further resistance determinants or mob-
like element except qnrD, such as integron structures and
transposons. Conjugal studies proved that all the isolates
failed to transfer the qnrD gene to E. coli C600 or E. coli J53
by liquid conjugation and filter mating, further supporting
the notion that the qnrD-carrying plasmids are untransfer-
able. In addition, the qnrD gene had emergedPlease cite this article in press as: Chen L, et al., Description and p
Wenzhou, Southern China, Journal of Microbiology, Immunology and Iindependently among our strains according to the PFGE
analysis. In other words, the qnrD gene did not have the
characteristic of horizontal transmission and clonal trans-
mission. Thus, the distribution of qnrD could be explained
from the perspective of bacterial evolution. Chromosomal
elements could transfer on their own or be mobilized by
transferable plasmids and research has shown that large
chromosomal elements could transfer via the mobilization
of segments of the chromosome by conjugative plasmids
through co-integration across identical insertion sequences
located on both replicons.21 It is possible that the qnrD
gene could be a product of co-integration in the bacterial
evolution process, involving only a segment of the chro-
mosome and attributed to acquired resistance through ge-
netic mutation under antimicrobial selective pressures. In
addition, the plasmid carrying qnrD showed a high similarity
with Providencia spp. and Proteus spp., which provided
evidence for the frequent association of qnrD with the
Proteeae. All the aforementioned information further
supports the conjecture that qnrD could be more closelylasmid characterization of the qnrD determinant in Proteeae in
nfection (2016), http://dx.doi.org/10.1016/j.jmii.2016.02.001
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and that Proteeae were an essential source or carrier of the
qnrD-harboring plasmids. By contrast, the plasmids carrying
qnrD were successfully transferred by transduction, and
transformants showed 62.5e300-fold increases in the MICs
of quinolones compared with recipient, which directly
proved that qnrD contributed to quinolone resistance and
suggested that the qnrD-carrying plasmids could spread via
other ways unlike conjugation, such as natural trans-
formation and transduction.
With regard to the mutation data of the QRDRs for all
qnrD-positive strains, we could not amplify the QRDRs in M.
morganii, which is likely because the primers used to
amplify the QRDRs for Enterobacteriaceae were not avail-
able for M. morganii and this is due to its unknown genome
according to the study of Mazzariol et al.22 There were no
mutations in the QRDR among other strains. This is similar
to previous studies, where topoisomerase mutations have
not always been investigated in qnrD-positive clinical
strains to evaluate how both mechanisms interact.17
In conclusion, qnrD genes are highly prevalent in Pro-
teeae clinical isolates in our hospital and the study results
suggest that qnrD could originate from Proteeae or could be
present in these bacteria as a reservoir; moreover, qnrD
could transfer and spread within the same or across
different bacterial species if the plasmid acquires mobile
elements under antimicrobial selective pressures.
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